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Cracking the carbohydrate code for selectin recognition 
Selectins are central in the inflammatory response; the discovery that they bind to 
carbohydrate ligands has galvanized carbohydrate chemists to search for inhibitors 
of the process. Recent progress in identifying and analyzing physiological selectin 
counter-receptors suggests new approaches to the design of ligands that bind 
to specific selectins. 
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White blood cells (leukocytes) circulate throughout the by designing specific antagonists, which may also serve as 
blood vasculature, patrolling the body for sites of tissue leads for therapeutics. 
damage or microbial infection. When such a site is 
encountered, the leukocytes must exit the blood stream Carbohydrate specificity of the selectins 
and migrate into the surrounding tissue to perform their The selectin family of adhesion molecules has three 
protective f&ctions. The sequence of events leading to members, E-, l’- and L-selectin (for a recent review see 
leukocyte recruitment, referred to as the inflammatory [a]). These share a common domain structure, which 
cascade, begins with the interaction of circulating leuko- includes an amino-terminal calcium-dependent (C-type) 
cytcs with endothelial cells lining the blood vessel (Fig. lectin domain, the sequence of which is highly conserved 
1) [II. First, the leukocytes tether to and roll along the between family members, an epidermal growth factor 
endothelial layer, propelled by the force of the blood (EGF)-like domain, and a series of short consensus repeat 
flow.The leukocytes then firmly adhere to the endothe- sequences that are homologous to complement regulatory 
lial layer, and migrate between endothelial cells to com- proteins. Expression of E- and P-selectin on the surface of 
plete their journey into the tissue. Although leukocyte endothelial cells is induced in response to inflammatory 
recruitment into the tissue is a normal, indeed essential, cytokines and microbial-derived toxins. E- and P-selectin 
component of the immune response, excessive and interact with carbohydrate-based ligands on leukocytes. In 
uncontrolled recruitment results in inflammatory disease. contrast, L-selectin is constitutively expressed on all classes 
Thus, when it was discovered that the initial rolling event of leukocytes in the blood and its ligands, also carbohy- 
in the inflammatory cascade is mediated by carbohy- drate-based, are found on endothelial cells. All three recep- 
drate-binding receptors, now called the selectins, carbo- tors have been shown in animal models to be important in 
hydrate chemists became the architects of a new era in acute and chronic inflammatory leukocyte recruitment; in 
anti-inflammatory drug design. Despite an explosion of different disease states, the selectin or selectins that are 
research on carbohydrate ligands for the selectins, efforts most important for recruitment vary. 
to design potent antagonists have met with only mar- 
ginal success. Here I summarize current views of The discovery of a C-type lectin domain in the three 
selcctill-carbohydrate recognition and suggest that recent selectins initiated the race to uncover complementary 
discoveries from the forefront of biological research in carbohydrate ligands. What emerged from these efforts 
this area offer new opportunities for chemists to con- was the discovery of a common motif recognized by all 
tribute to the understanding of these biological processes three selectins, the sialylated and fucosylated tetrasaccharide 
Fig. 1. The multistep process of leuko- 
cyte recruitment from the bloodstream 
into the surrounding tissue. The first step 
in leukocyte recruitment is the initial 
tethering and rolling of leukocytes along 
the endothelial cells of the blood vessel 
wall. The tethering and rolling steps are 
mediated by the interaction of the 
selectins with complementary counter- 
receptors. The subsequent steps of acti- 
vation, firm adhesion and migration 
involve adhesion molecules of the inte- 
grin and immunoglobulin families, 
along with soluble chemokines and 
other signaling molecules. 4 Chemistry & Biology, 1995 
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sialyl Lewis x (sLe”, NeuAccu2,3Galpl ,4(Fuccul,3)GlcNAc, 
compound 1, Fig. 2) and a related structure, sialyl Lewis a 
(sLe”, NeuAccu2,3Gal~l,3(Fuccxl,4)GlcNAc) [3,4]. These 
two oligosaccharides differ in their l inkages of galactose and 
fucose to N-acetylglucosamine, but share a similar spatial 
orientation of galactose, fucose and sialic acid. The func- 
tional groups that interact directly with the selectin binding 
pocket are thought to be on the sialic acid, fucose and 
galactose moieties, whereas N-acetylglucosamine serves pri- 
marily as a scaffold. Selectin binding to sLe’ under equilib- 
rium conditions is fairly weak; the K, for sLey binding to 
E-selectin has been reported to be in the millimolar range 
[5,6]. Nonetheless, sLe” is an effective anti-inflammatory 
agent in several acute disease models [7-101 and is currently 
in clinical trials.The components of sLeY that contribute to 
selectin binding have been probed extensively using syn- 
thetic sLe’ analogs. It is remarkable that derivatives in which 
the sialic-acid residue was replaced with a sulfate ester (3’- 
sulfo LeS) were equally active in binding all three selectins, 
implying that any anionic substituent at the 3-position of 
the galactose residue might impart selectin-binding activity 
111-141. This discovery was embraced by carbohydrate 
chemists interested in inhibitor design, as it offered a 
welcome reprieve from the difficulties of sialic acid chen- 
istry.The hydroxyl groups of fucose were found to be criti- 
cal for binding to all three selectins (14,151, whereas a 
variety of substitutions appear to be permitted at the 2- 
position of N-acetylglucosamine [I 61. These observations 
indicate that the recognition domain on sLe” comprises the 
carboxylate group of sialic acid and the hydroxyl groups of 
fucose and galactose (Fig. 2), which are all found on one 
face of the molecule in the solution structure of sLe’ as 
determined by NMR [17,18]. 
Central to any drug design effort is an accurate structural 
model of the receptor-ligand interaction. Unfortunately, a 
high-resolution crystal structure of a selectin bound to 
sLe” is not yet available. The three-dimensional structure 
Sialyl Lewis x (sLeX, 1) 
NeuAccu2,3Gal~l,4~Fucal,3]GlcNAc 
‘OR 
Fig. 2. Sialyl Lewis x (sLeX), a recognition motif common to the 
selectins. The highlighted functional groups are essential for selectin 
binding and form a recognition domain along one face of the 
tetrasaccharide. NeuAc = N-acetylneuraminic acid (sialic acid), 
Gal = galactose, Fuc = fucose, GlcNAc = N-acetylglucosamine. 
Key positions referred to in the text are numbered. 
Fig. 3. A  proposed model for sLeX bound in the lectin domain of E- 
selectin. This model is based on the crystal structure of E-selectin 
and the bound conformation of sLeX determined by NMR. In this 
model, sLeX binds in a shallow pocket delineated by Lys99 
(orange) and the bound calcium ion (cyan). A  critical residue, 
Arg97, interacts with the carboxylate of sialic acid, and the 2- and 
3-hydroxyl groups of fucose are coordinated to calcium. 
of E-selectin without bound ligand has been reported 
[ 191, however, and several models for selectin-sle’ binding 
based on the structure of the homologous mamrose 
binding protein (MBP) with bound mannose [20], have 
been proposed. Two general models have emerged from a 
combination of computer modeling, mutagenesis studies 
and structure-activity correlations with sLe’ derivatives. 
The first model, proposed by Erbe ct 01. 121.221, Bajorath 
and coworkers 123-251 and Graves CT ill. [ 191, was derived 
using the preferred solution conformation of sLeX. The 
second model, proposed by Kogan ct 01. [26], used the 
conformation of sLe” bound to E-selectin as determined 
by NMR [ti] (Fig. 3). In both models, the 2- and 
3-hydroxyl groups of fucose are predicted to coordinate 
with a bound calcium ion, similar to the coordination of 
mannose in MBPThe major difference between the two 
models lies in the relative orientation of sialic acid. In the 
first model, Lysl 13 and Lysl 1 1, which are conserved 
among the selectins, interact with the carboxylate group of 
sialic acid. In the second model, the sialic acid is oriented 
such that the carboxylatc group interacts favorably with 
Arg97.The second model is supported by the observation 
that mutation of Lysl13 to glutamic acid has no detri- 
mental effect on E-selectin binding. This result is inconsis- 
tent with the idea that this residue has an ionic interaction 
with sialic acid, and suggests that Lysl 13 contributes to 
sLe” binding via an alternative mechanism. 
Kiessling and coworkers [27] examined the effects of 
galactose modifications on selectin binding to the Lewis a 
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able 1. Glycomimetics of sLex and their relative binding 














Compounds with values greater than 1 bind E-selectin wit1 
greater affinity than sLex, whereas compounds with values les 
ban 1 bind E-selectin with weaker affinity. 
trisaccharide. It is interesting that sulfation of the &OH 
ofg&ctose in 3’-culfo Le” caused a dramatic reduction in 
E-selectin binding activity. In the second model for 
E-selectin binding, the &OH of galactose is involved in a 
critical hydrogen baud with Tyr94 and is positioned near 
Glu80, which might explain the weakened binding of the 
sulfated derivative. Future binding studies with mutant 
selectins and conlplementary synthetic sLex analogs may 
allow further refinement of ligand-binding imodels. Still, 
the ultimate proof of any proposed nlodel awaits the 
structure of a sele&-l&and co-crystal. 
Glycomimetics as selectin antagonists 
Sialylated and fLlcosylated oligosaccharides such as sLe’ 
are difficult and expensive to synthesize. Thus, arnled 
with a collection of data from structure-activity relatioIi- 
ships and binding models, several synthetic &enlists have 
designed sLe’ mirnetics endowed with the rninirnal 
requirements for selectin binding. Sonle examples are 
shown in Table 1 with their E-selectin binding potencies 
conlparcd to that of sLe’ (compound 1). Conlpound 2 
contains fucose and galactose residues joined by a short 
linker; a simple acidic cubstituent replaces sialic acid [28]. 
Compound 3 is fxther sinlplified with replacement of 
galactose by an amino-acid diol [28]. An even smaller 
derivative, compound 4, is conlposed of a monosaccha- 
ride minlic of fucose (niannose) tethered to a carboxylic 
acid by a rigid hydrophobic spacer [29]. It is remarkable 
that minleticc 2-4 are conlparable to sLe” in their 
binding to E-selectin. Compounds 5 and 6, in which 
f _ ’ d ._ 1’ - -‘d :‘d ucosc ai sid ic aci reji Lies are tethered by a rigid or 
flexible linker, rerpectively, show diminished E-selectin 
binding activity coInpared to sLer [30,31]. The nlost 
effective glycominletic E-selectin inhibitor described to 
date is con~pound 7, which was designed based on the 
results of a conlputer-aided search using sLc’ as a basis 
structure 1-121. But as yet, no truly potent (by which I 
mean, having an ICs,, in the nanornolar or low nlicro- 
molar range) selectin inhibitor has been derived from 
sLex pharrmacophores. 
Physiological selectin counter-receptors provide new leads 
for drug design 
The pursuit of selectin antagonists has centered on the 
conmmon sLe” binding activity of the three selectins i,l 
vitro. It is now apparent, however, that selectin binding irl 
Go is a nlore complicated nlatter, involving distinct 
binding specificities in different tissue sites. The picture 
enierging front biological studies is that each selectin 
recognizes a discrete set of glycoprotein nlolecules on 
opposing cells, and that these physiological counter- 
receptors present the proper carbohydrate-based epi- 
topes for optimal velectin binding irl V/IN. Several sclcctin 
counter-receptors have now been cloned and biocheln- 
tally characterized, exposing a nunlber of different 
mechanisnls by which nature has achieved selectin 
specificity (Fig. 4). 
Three phyriological counter-receptors for L-selectin 
have been identified, GlyCAM-I [33]. CD34 (341 and 
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MAdCAM- [35,36]. These glycoproteins share two 
structural features: dense clusters of serine and threo- 
nine residues that are modified with O-linked 
oligosaccharide chains, and oligosaccharide structures 
that bind to L-selectin. Although the GlyCAM-1, 
CD34 and MAdCAM- polypeptides are expressed in 
different tissues, the proper glycoforms for L-selectin 
binding are restricted to endothelial cells at sites of 
leukocyte recruitment. 
The oligosaccharides on GlyCAM-I have been analyzed 
in detail, culminating in the diccovery of two novel 
structures, h’-sulfo sLe” (NeuAccu2,3(S03-6)GaIpl ,-t- 
(Fucal,3)GlcNAc) and 6-sulfo sLeX (NeuAccu2,3- 
Gal@1 ,4(Fuccul,3)(S03-6)GlcNAc) [37-391, which cap 
the majority of the oligosaccharide chains. Based on the 
observation that sulfation of GlyCAM-1 is required for 
L-selectin binding [IO], it was proposed that sulfation of 
the &hydroxyl group of galactose or N-acetylglu- 
cosamine increases the affinity of sLe” for L-selectin. 
Consequently, a new stratecq for the design of L-selectin 
antagonists might involve the installation of sulfate esters 
on the appropriate positions of a core structure related to 
sLe” [41]. Indeed, the disaccharide lactose h’,h-disulfate, 
which is sulfated at positions analogous to those found 
on the GlyCAM-1 oligosaccharides, is more potent than 
sLe’ as an L-se&tin inhibitor [42]. Other structural fea- 
tures of GlyCAM- 1, such as the organization of oligo- 
saccharides along the peptide backbone, may also be 
relevant to inhibitor design. 
The only physiological counter-receptor for P-selectin 
that has been identified at the molecular level is the 
leukocyte-associated glycoprotein PSGL-1 143,441. Like 
the L-selectin counter-receptors, PSGL-1 possesses 
regions of densely clustered oligosaccharides bound to 
scrine and threonine residues, and the oligosaccharide 
chains are capped with sLeg-like structures [45]. PSGL-1 
has an additional feature, however, that is not shared by 
the L-selectin counter-receptors - an amino-terminal 
domain with a consensus sequence for tyrosine sulfation. 
Recent data suggest that sulfated tyrosine residues within 
this domain and sLe”-like epitopes on a separate region 
of the glycoprotein are both essential for functional 
Kselectin binding activity [46,47].This startling discov- 
ery suggests a model for P-selectin binding that includes 
protein recognition in addition to carbohydrate recogni- 
tion, dramatically diverging from traditionally held 
views. The discovery of a tyrosine-sulfated peptide as a 
structural motif for P-selectin recognition offers new 
approaches for the design of experimentally and thera- 
peutically useful molecules. Novel inhibitors can be 
designed to include both tyrosine sulfate and sLe” moi- 
eties. In addition, readily available aryl sulfatases, which 
cleave tyrosine sulfate esters, may have therapeutic value 
in preventing P-selectin adhesion to PSGL-1 
The bifunctional nature of P-selectin/PSGL-1 recogn- 
tion invites speculation about the mechanics of the inter- 
action. Sako it a/. 1471 proposed a model in which the 
lectin domain of P-selectin binds specifically to sLe’-like 
epitopes, while a secondary binding region, perhaps 
within the EGF domain, engages in non-specific electro- 
static interactions with the sulfated region of PSGL-1. 
From this perspective, P-selectin binding to PSGL-1 may 
be mechanistically similar to DNA recognition by a 
subset of l)NA-binding proteins known to engage in 
both non-specific electrostatic interactions with the 
phosphodiester backbone and in specific hydrogen bonds 
within the major groove [4X].Tl it se 1 q uence-non-specific 
electrostatic interactions greatly increase the association 
rate. Likewise, non-specific electrostatic interactions 
Fig. 4. The selectins and their physiolog- 
ical counter-receptors. The three known 
L-selectin counter-receptors, GlyCAM-1, 
CD34 and MAdCAM-1, are mucin-like 
molecules with densely clustered O- 
linked oligosaccharides. The GlyCAM-1 
oligosaccharides are capped with 6’. 
and &sulfated sLex groups, and the 
oligosaccharides of the other two 
L-selectin counter-receptors probably 
bear similar structures. The P-selectin 
counter-receptor PSGL-1 is a mucin-like 
homodimer with sLeX-like structures on 
O-linked oligosaccharide chains and an 
amino-terminal domain bearing sulfated 
tyrosine residues. The E-selectin 
counter-receptor ESL-1 is a globular gly- 
coprotein with five potential N-linked 
glycosylation sites. 
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A ph) siologlcd CoUlltel-~l-eCL’PtOf for E-sclectin, ESL- I , 
h.l\ .rlw bcm identitied [49].This glycoprotcin is unicpc 
‘I111011~ the wlcctiii coullter-I-eceptors ii) th,lt the 
oli~:o~,lccharidc sulxtitucnts ~ppedr to lx priiiicli-il~ 
.I,p,lr,1~illt’-lillk~‘~ (N-linked). Furthernlorc, ESL- 1 his 
only h1.c potwti:~l site of N-linked glycosylation. ill 
ark contr.lst to GlyCAM-I. (X134 md I’SGL-I. \vhich 
1 1‘IVC‘ lllucln-like structures xvitli mdny potmtial 
~cl-itle/thr~ollill~-linked (O-linked) glycosyl,ltion sita. 
‘fhc Inulti\.,llcnt intcrclction of J muciwlike glycopro- 
tc’ill n.itli several selcctin iiiolecules mdy contribute 
\troiigly to high-,i\:iciity L- ad I’-selectin binding dnd 
111.1). he .I rc~q~iirciiient for adlie~ioii under conditions 
u.li~w the cell i\ under die,li- stress. ds it is iii d blood 
\-c\\c>l due to blood tlo\v. Cl~xly ESL-1 1s llot endo\vcd 
1~ ith the wiiic dcgrcc of multivalency md high-midit) 
E-x>lc%ctin biiidiiig iiilcit imnlve different nicchmiwi5. 
The lrcprt of L~~USLIJ~ tctr,l-,lntellll~l1ry N-linked oligo- 
uclurides \vith high affinity for E-selcctin [50] is mm-thy 
of ~lote.Tl~cw oIi~os,lcch,lridcs bear a dif~lws):l~~ted sLe’- 
like cpitopc (di-{Le’) oil oiic brmch, alld varioirsly sialy 
l,ltcd structures on the other three branches. The K, 
L.,I~LIC‘\ of the 111onomeric oligosacch,ll-ides with E-selectin 
\v~w e\tim,ltcd to be < I pM, in contrclst to -1 mM foi,r 
\Lc’.Tlic sti-ucturdl origin of the iiiiusuatly high l>iiidiiig 
,iftinity 1i,1\ not yet bee~i determined, but inay Lx d coiiv- 
q~iciicc of i,l\orahle coiit,lcts \\:itti c.dx~hydrate iuidues 
bC\Y~lld the jLc“ c,lpping y-oup. Alttwmivcl~: the envi- < 
1mllnient of the \Lc’ t~trdsciccticiride \vittiin the hraiictic~~ 
mucturc imy iiiipow conti,rm,ltioiiat restrictions tli,it 
lo\\ i’r ttic eliti-epic cost of E-wlectin complcxcition 15 1 1. 
If the ESL- I oligos,lccharides bind E-sclectin with affin- 
tic5 siliiildr to tliow of the tc’trd-diitC’liliar)’ olig~wccli,1- 
ricicx .I high ilcgrec of multivalency ma)- not lx rcquircd 
to .Icliicvc c-e11 ,itltieGoli under the conditions of blood 
tlo\c Tti~w oti~o\acclidride structurrs, which hind to 
Edc~lcctiii \\.itli hi& ,itiinit): nidy pi-ovidc iic\\ insights 
into the deign of Emselectill ant,pni~ts. 
Future perspectives 
Ii1 ~li111111dr): sl-c’ is d good stm-ting point for the design of 
\ctc,ctin xitapiists. but tilrttier progrw lvill require d 
bcttel- undt’nt,iiiding of the structural rcquirciiients for 
\clcxmn billding ,~nd speciticitv. Although much has been 
lc,rrncd 111 the 5is ycan since the dixwvery of the selectin 
t;iliiil!. tllc ~~~olec~ilcs rcspoiisibtt’ for selectin-inedi‘itec 
.1dlic~5ion irr 11irw x-e only now beiii g chxacterized Iit the 
lllolc~~ulclr Icvel.The pliysiotoSicd1 selectiii counter-recep- 
to]-\ hex \idtyldted mci fiicosyldted oligosac~liarid~s 
rcl‘ltcJ to \L.C’ . .I shad fcaturc recluircd for selectiii 
l>iiidiii~:. But it is the diffcrenccs among the sclcctin 
ColiIitt’r~i-l’C‘C’t~toi-~ tlidt drc most intriguing ,ind thdt offer 
cllcllllst\ lle\v dvt‘nut5 for therapeutic intervention: thdt 
is, \ulfiltcd 0-link4 oli~osacch~wides on <;ly<IAM-I 
(L-\clcctitl), tyrcninc culf,ltc‘ on l’S<;L-I (l’+electin), ,lnd 
Rostvl, S.D. R B&orri, C.R I lW41. The selectins antI their lip+~nds. 
C‘un. O/"II. Cd/ Hid 6, 66-67 3 
Id< oh, G.S., rl JI., S Scutldcr, I’. II YY51. Binding oi \i,llyl LIWIS * lo 
E-irleclin rls med5urd hv tluorcsc-rncex polarlr,ttlon. Bloc-hcmistr\ 
34,1’10-1217. 
Cookt,. R.M., Hale, R.S., I.lster, 5 C., Shah, G. & 1Veir. M.P. 1lYY41. 
B&rkv, C1:, LVVcyrich, ,\.S., Zheng, Z., Caet,,, F.(., Forwit, 1M.l. 
X I eirr, A.M. (1 YWI. Sid\ I Lc\vls s-cont,uninti olirosaccharlde 
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